Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Pharming Group N.V.
  6. Summary
    PHARM   NL0010391025

PHARMING GROUP N.V.

(PHARM)
  Report
Real-time Euronext Amsterdam  -  11:35 2022-09-23 am EDT
1.098 EUR   -2.31%
09/23PHARMING N : Halfjaarlijkse financiële verslaggeving
PU
09/21PHARMING N : BlackRock Inc. - Pharming Group N.V. - Leiden
PU
09/16PHARMING N : BlackRock Inc. - Pharming Group N.V. - Leiden
PU
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Real-time Quote. Real-time Euronext Amsterdam
09/19/2022 09/20/2022 09/21/2022 09/22/2022 09/23/2022 Date
1.17(c) 1.173(c) 1.173(c) 1.124(c) 1.098(c) Last
9 392 908 4 290 686 4 141 254 6 288 069 7 007 293 Volume
-5.95% +0.26% 0.00% -4.18% -2.31% Change
More quotes
Estimated financial data (e)
Sales 2022 205 M 199 M 199 M
Net income 2022 15,2 M 14,8 M 14,8 M
Net cash position 2022 79,3 M 77,1 M 77,1 M
P/E ratio 2022 30,5x
Yield 2022 -
Sales 2023 235 M 229 M 229 M
Net income 2023 9,23 M 8,98 M 8,98 M
Net cash position 2023 170 M 165 M 165 M
P/E ratio 2023 51,1x
Yield 2023 -
Capitalization 716 M 697 M 697 M
EV / Sales 2022 3,11x
EV / Sales 2023 2,32x
Nbr of Employees 277
Free-Float 98,2%
More Financials
Company
Pharming Group N.V. specializes in the development of innovative products for the treatment of genetic disorders, specialty products for surgical indications, and nutritional products. The group's technologies include innovative platforms for the production of protein therapeutics, as well as technology and processes for the purification and formulation of these products. Net sales are distributed geographically as... 
Sector
Pharmaceuticals
Calendar
10/27 | 01:00amEarnings Release
More about the company
Ratings of Pharming Group N.V.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about PHARMING GROUP N.V.
09/23PHARMING N : Halfjaarlijkse financiële verslaggeving
PU
09/21PHARMING N : BlackRock Inc. - Pharming Group N.V. - Leiden
PU
09/16PHARMING N : BlackRock Inc. - Pharming Group N.V. - Leiden
PU
08/04TRANSCRIPT : Pharming Group N.V., H1 2022 Earnings Call, Aug 04, 2022
CI
08/04PHARMING N : Group reports financial results for the first half of 2022
PU
08/04Pharming Group N.V. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
08/04PHARMING GROUP N.V. : Corporate officers' Statement : transactions in the company's secur..
CO
08/04PHARMING GROUP N.V. : Half-year results
CO
08/04PHARMING GROUP N.V. : Press Release
CO
08/04PHARMING N : H1 2022 Financial Results Presentation
PU
08/04Pharming Group N.V. Announces Resignation of Robert Friesen, Chief Scientific Officer a..
CI
08/04PHARMING GROUP N.V. : Corporate officers' Statement : transactions in the company's secur..
CO
08/04PHARMING GROUP N.V. : Corporate officers' Statement : transactions in the company's secur..
CO
08/04PHARMING GROUP N.V. : Corporate officers' Statement : transactions in the company's secur..
CO
08/04PHARMING GROUP N.V. : Corporate officers' Statement : transactions in the company's secur..
CO
More news
News in other languages on PHARMING GROUP N.V.
09/23AEX toch weer lager van start gegaan
09/22BlackRock verkleint belang in Pharming
09/17BlackRock verkleint belang in Pharming
09/16BlackRock vergroot belang in Pharming
09/15AEX licht hoger van start gegaan
More news
Analyst Recommendations on PHARMING GROUP N.V.
More recommendations
ETFs positioned on PHARMING GROUP N.V.ETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
IShares MSCI Netherlands ETF - USD0.3%-7.61%dutch
UBS ETF - MSCI EMU Small Cap A-dis - EUR0.1%0.95%Europe
Lyxor MSCI EMU Small Cap (DR) - Dist - EUR0.09%-6.03%Europe
BMO MSCI Genomic Innovation Index ETF - CAD0.09%0.00%-NC
IShares MSCI Europe Small-Cap ETF - USD0.04%-9.41%Europe
More ETFs positioned on PHARMING GROUP N.V.
Chart PHARMING GROUP N.V.
Duration : Period :
Pharming Group N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PHARMING GROUP N.V.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 1,10 €
Average target price 1,78 €
Spread / Average Target 62,1%
EPS Revisions
Managers and Directors
Sijmen de Vries Chairman-Management Board, CEO & CFO
Jeroen Henk Wakkerman Chief Financial Officer
Paul Jai Sekhri Chairman
Anurag Relan Chief Medical Officer
Robert Friesen Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
PHARMING GROUP N.V.41.68%697
JOHNSON & JOHNSON-2.54%438 337
ELI LILLY AND COMPANY12.54%295 941
ROCHE HOLDING AG-18.41%259 291
ABBVIE INC.5.66%252 944
PFIZER, INC.-25.35%247 392